New skin cream shows promise for taming severe eczema
Disease control
Completed
This study tested a new ointment called LNK01004 for adults with moderate to severe atopic dermatitis, also known as eczema. About 75 participants applied one of two strengths of the ointment or a placebo cream twice daily for 8 weeks. The main goal was to see how well it reduced…
Phase: PHASE2 • Sponsor: Lynk Pharmaceuticals Co., Ltd • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC